Triple
T701554
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | 2009 H1N1 influenza pandemic |
E14008
|
entity |
| Predicate | antiviralTreatment |
P4714
|
FINISHED |
| Object |
oseltamivir
Oseltamivir is an oral antiviral medication (commonly known by the brand name Tamiflu) used to treat and prevent influenza, including pandemic strains such as 2009 H1N1.
|
E85057
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: oseltamivir | Statement: [2009 H1N1 influenza pandemic, antiviralTreatment, oseltamivir]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: oseltamivir Context triple: [2009 H1N1 influenza pandemic, antiviralTreatment, oseltamivir]
-
A.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
-
B.
Vumerity
Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
-
C.
Plegridy
Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
-
D.
Activase
Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
-
E.
Tylenol
Tylenol is a widely used over-the-counter pain reliever and fever reducer whose active ingredient is acetaminophen (paracetamol).
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: oseltamivir Triple: [2009 H1N1 influenza pandemic, antiviralTreatment, oseltamivir]
Generated description
Oseltamivir is an oral antiviral medication (commonly known by the brand name Tamiflu) used to treat and prevent influenza, including pandemic strains such as 2009 H1N1.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: oseltamivir Target entity description: Oseltamivir is an oral antiviral medication (commonly known by the brand name Tamiflu) used to treat and prevent influenza, including pandemic strains such as 2009 H1N1.
-
A.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
-
B.
Vumerity
Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
-
C.
Plegridy
Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
-
D.
Activase
Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
-
E.
Tylenol
Tylenol is a widely used over-the-counter pain reliever and fever reducer whose active ingredient is acetaminophen (paracetamol).
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: antiviralTreatment Context triple: [2009 H1N1 influenza pandemic, antiviralTreatment, oseltamivir]
-
A.
treats
Indicates that one entity provides medical care or therapeutic intervention to another entity.
-
B.
treatment
chosen
Indicates that one entity is used as a medical or therapeutic intervention to address, manage, or cure a condition affecting another entity.
-
C.
typeOfRemedy
Indicates that one entity is a specific kind or category of remedy in relation to another entity.
-
D.
treatmentCountry
Indicates the country where a treatment, therapy, or medical intervention is administered or takes place.
-
E.
remedy
Indicates that one entity serves to cure, alleviate, or counteract a problem, illness, or undesirable condition affecting another entity.
- F. None of above.
Provenance (6 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a493494ec48190ae6751683625a9ba |
completed | March 1, 2026, 7:28 p.m. |
| NER | Named-entity recognition | batch_69a4a544e3608190ac315c7aa9f88e7e |
completed | March 1, 2026, 8:44 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a5dcae2ef88190a9ea1604429f048a |
completed | March 2, 2026, 6:53 p.m. |
| NEDg | Description generation | batch_69a5df14e1788190bb2f2cc87cadcb40 |
completed | March 2, 2026, 7:03 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69a5ff5dd4808190bb8ae25fbdca0075 |
completed | March 2, 2026, 9:21 p.m. |
| PD | Predicate disambiguation | batch_69a4a4ec8c748190b198492a0eea4445 |
completed | March 1, 2026, 8:43 p.m. |
Created at: March 1, 2026, 7:36 p.m.